Your point that the use of AS at the NIH might have severely impacted our patent is IMO totally incorrect. If they had offered and the offer was accepted, we already would have EPA and patent approvals.To have the NIH and the CDC as your friend would be a "Big Deal" and we wouldn't be trading at .10 to .12, meanwhile we wait and wait. JMO!!!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.